Experts are keenly watching retatrutide, a novel treatment presenting promising data in real-world trials for obesity loss . This double-action substance, targeting both GLP-1 and gut-hormone pathways, seems to offer a significant advance over existing weight-loss medications . Early findings suggest greater efficacy in helping individuals reac… Read More